ArticleInfectious agents and cancer2025

Plasma Epstein-Barr virus DNA for the prediction of treatment response and disease progression in non-keratinizing differentiated nasopharyngeal carcinoma.

Guan-Zhong Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.